MANCHESTER biotech firm Intercytex said today it has completed the sale of the stem cell assets of its subsidiary Axordia as it ploughs on with the break-up of the group.

The group also revealed that its last three employees – executive directors Nick Higgins, Paul Kemp and Max Herrmann – have been put on notice and will leave the group once the sell-off is complete.

The assets have been bought by drugs giant Pfizer from $750,000. In a statement to the market Intercytex said £75,000 will be held in ......for the full story register now for free or login below...